Show up before the problem does.
International open call built on real clinical pain points around prevention, with a direct path to a Lisbon pilot.
Prevention
Oncology
Cardiology
Respiratory
Prevention Oncology Cardiology Respiratory
Prevention
Oncology
Cardiology
Respiratory
Prevention Oncology Cardiology Respiratory
Strategic Partners
Corporate Partners
Challenge Partners
The numbers speak for themselves.
Non-communicable diseases (NCDs), including cardiovascular diseases, cancer and chronic respiratory diseases, account for approximately 75% of all deaths worldwide.
Yet, across the European Union, only 3-5.5% of total health expenditure is allocated to prevention.
Sources: WHO 2021
OECD/European Commission, Health at a Glance: Europe 2024/2025
Why does prevention matter specially in oncology, cardiology & respiratory?
LET’S MOVE THE NEEDLE
So is the opportunity. Are you in?
The gap is real.
LET’S MOVE THE NEEDLE
THE ASK
Fix the prevention challenges hospitals can’t crack alone.
Built on real hospital problems. Not hypotheticals. Answer one.
Primary Prevention
-
Therapeutic Inertia Gap: Known CV risk factors go untreated. Seeking decision-support and accountability tools that shift clinician and patient behaviors at scale.
Cardiometabolic Prevention Gap: Cardiovascular risk factors rarely come alone: hypertension, diabetes, obesity, dyslipidemia, smoking and sedentary behaviour cluster and compound. Yet care remains siloed. Seeking solutions that detect undiagnosed or insufficiently controlled patients early, and deliver truly integrated intervention across primary care, hospital, community and the patient themselves, addressing the full continuum, not just the diagnosis.
-
Cessation programs are live in primary care but fragmented. Seeking platforms combining risk stratification, behavioural monitoring and incentive mechanisms, turning awareness into sustained, measurable cessation in documented high-risk cohorts.
-
Intelligent Patient-to-Specialist Routing: In Lisbon's hospital network, avoidable referral delays and missed prevention programs entry points represent a significant, recoverable gap.
Seeking AI-driven routing and clinical triage platforms; decision support for referral optimization; risk stratification tools that operate across specialty boundaries without adding new clinical workflows. Getting the right patient to the right specialist at the right moment.
Secondary Prevention
-
Acute Cardiac Event Detection: Real-time monitoring for early MI and arrhythmia - intelligent contextualization and automated care-seeking, without added clinical friction.
Vulnerable Plaque Imaging: AngioTAC and MRI miss non-obstructive high-risk plaques. Seeking AI imaging analytics to close this diagnostic gap before acute events occur.
Heart Failure Prevention Gap: Heart failure is often the end result of hypertension, diabetes, renal disease, obesity, atrial fibrillation or coronary disease. Yet most patients arrive after the first decompensation. Seeking proactive pathways that identify at-risk individuals before hospitalization, combining biomarkers, diagnostics, clinical assessment and closed-loop referral.
-
Clinical trial recruitment: Gaps between Clinical Research Center and frontline oncology teams create missed recruitment windows. Seeking real-time trial visibility platforms connecting clinicians and patients and linking ULS Santa Maria to European oncology and clinical research networks.
Smart Screening: Seeking AI engagement platforms and multi-gene risk algorithms operating at scale independent of clinical staff availability routing the right people to oncology before symptoms emerge.
-
GPS-Guided Nodule Access: Image-guided navigation for minimally invasive small nodule access improving precision and reducing patient discomfort.
Incidental Finding Alerts: Pulmonary anomalies in non-pulmonology imaging risk being lost between departments. Automated cross-specialty alerts for timely follow-up.
Tertiary Prevention
-
Digital Survivorship: As cancer survival improves, post-treatment follow-up becomes the new clinical frontier. Continuous monitoring for early recurrence signals and late treatment toxicity with personalized reintegration pathways coordinated between oncology and primary care.
-
Remote Respiratory Rehabilitation: Home-based delivery of clinically viable rehab exercises. Reducing secondary care demand while maintaining clinical oversight.
Chronic Telemonitoring: Remote monitoring with digital auscultation for chronic respiratory patients - earlier intervention, fewer readmissions.
WE OPENED THE DOOR.
WALK TRHOUGH IT WITH YOUR USE CASE.
WE OPENED THE DOOR. WALK TRHOUGH IT WITH YOUR USE CASE.
THE JOURNEY
THE JOURNEY
Your path from challenge to real-world pilot.
The program moves fast. From application to the Web Summit stage in six weeks, with real clinical feedback at every step and a pilot proposal waiting at the finish line.
Applications
1
SET 01 - OCT 04
SET 01 - OCT 04
Applications
Startups submit their application to the international open innovation call.
1
Jury Day
2
Startups submit their application to the international open innovation call.
OCT 23
OCT 23
A full day, face-to-face with the hospitals. Get in the room, pressure-test your use case and walk away sharper than you started. Only the top 9 move on.
The 20 shortlisted startups pitch online to a panel of clinicians and jury members. Only the top 9 move on to the Prevention Day.
Prevention Day
Step into the room where clinical deals happen and win Pilot Meetings, Global Soft-Landing Support, or a Web Summit Stage presentation (Top 3).
2
3
NOV 04
3
NOV 9-12
Jury Session
Prevention Day
4
Web Summit
4
Web Summit
NOV 9-12
The top 3 take the Web Summit stage in Lisbon with global visibility and a pilot proposal ready to launch.
The top 3 take the Web Summit stage in Lisbon with global visibility and a pilot proposal ready to launch.
Step into the room where clinical deals happen and win Pilot Meetings, Global Soft-Landing Support, or a Web Summit Stage presentation (Top 3).
NOV 05